A pandemic may be a tough time to test a new technology, but that’s exactly what COVID-19 vaccine experts are doing, with encouraging results. Two of the first shots that could be injected into people’s arms as early as December, from Pfizer and Moderna, rely on a new technology based on a genetic material called mRNA.This method is both fast and flexible; vaccine makers don’t need to grow or manipulate the COVID- 19 virus—all they need is its genetic sequence.That efficiency led to shots that are more than 90% effective in protecting against COVID-19, which were developed and tested in record time. —Alice Park
More Must-Reads From TIME
- Why Cell Phone Reception Is Getting Worse
- The Dirty Secrets of Alternative Plastics
- Israeli Family Celebrates Release of Hostage Grandmother
- We Should Get Paid for Our Online Data: Column
- The COP28 Outcomes Business Leaders Are Watching For
- The 100 Must-Read Books of 2023
- The Top 100 Photos of 2023
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time
